Scholarly Index
Lars Gullestad
Oslo University Hospital; 27,370 total citations; 644 total publications; best world rank #42
Oslo University Hospital
27,370Total citations
644Total publications
81H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Transplantation: Methods and Outcomes | Lifetime | 54 | NO 1 | 99.45 |
| Cardiac Fibrosis and Remodeling | Lifetime | 42 | NO 2 | 99.14 |
| Viral Infections and Immunology Research | Lifetime | 179 | NO 1 | 98.69 |
| Signaling Pathways in Disease | Lifetime | 110 | NO 1 | 98.44 |
| Heart Failure Treatment and Management | Lifetime | 335 | NO 3 | 98.74 |
| Cardiovascular Function and Risk Factors | Lifetime | 702 | NO 7 | 98.79 |
| Mechanical Circulatory Support Devices | Lifetime | 421 | NO 5 | 98.22 |
| Cardiovascular and exercise physiology | Lifetime | 620 | NO 15 | 97.47 |
| Renal Transplantation Outcomes and Treatments | Lifetime | 679 | NO 6 | 97.55 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 473 | NO 6 | 96.93 |
| Chemokine receptors and signaling | Lifetime | 620 | NO 10 | 92.53 |
| Heart rate and cardiovascular health | Lifetime | 287 | NO 5 | 84.92 |
| Transplantation: Methods and Outcomes | 2021-2025 | 435 | NO 1 | 92.18 |
| Cardiovascular and Diving-Related Complications | 2021-2025 | 315 | NO 3 | 75.85 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 431 | NO 3 | 69.40 |
| Cardiac Fibrosis and Remodeling | 2021-2025 | 793 | NO 12 | 64.66 |